1. Home
  2. OSS vs PEPG Comparison

OSS vs PEPG Comparison

Compare OSS & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OSS

One Stop Systems Inc.

N/A

Current Price

$4.35

Market Cap

147.4M

Sector

Technology

ML Signal

N/A

Logo PepGen Inc.

PEPG

PepGen Inc.

N/A

Current Price

$2.46

Market Cap

163.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSS
PEPG
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
163.5M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
OSS
PEPG
Price
$4.35
$2.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
★ $15.33
$10.19
AVG Volume (30 Days)
★ 1.3M
1.0M
Earning Date
10-28-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 133.85
25.61
EPS
★ N/A
N/A
Revenue
★ $37,027,382.00
N/A
Revenue This Year
$39.68
N/A
Revenue Next Year
$16.26
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 34.46
N/A
52 Week Low
$4.17
$1.31
52 Week High
$20.88
$7.80

Technical Indicators

Market Signals
Indicator
OSS
PEPG
Relative Strength Index (RSI) 27.58 45.65
Support Level N/A $2.24
Resistance Level $7.13 $2.62
Average True Range (ATR) 0.45 0.23
MACD -0.08 -0.01
Stochastic Oscillator 13.85 25.33

Price Performance

Historical Comparison
OSS
PEPG

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: